1. Home
  2. NKTR vs BY Comparison

NKTR vs BY Comparison

Compare NKTR & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$71.50

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Byline Bancorp Inc.

BY

Byline Bancorp Inc.

HOLD

Current Price

$39.34

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
BY
Founded
1990
1914
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
NKTR
BY
Price
$71.50
$39.34
Analyst Decision
Strong Buy
Buy
Analyst Count
7
2
Target Price
$146.67
$36.00
AVG Volume (30 Days)
833.2K
303.7K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
1.48%
EPS Growth
N/A
5.09
EPS
N/A
0.83
Revenue
$307,711,000.00
N/A
Revenue This Year
N/A
$16.89
Revenue Next Year
N/A
$3.15
P/E Ratio
N/A
$47.17
Revenue Growth
86.00
N/A
52 Week Low
$21.02
$25.38
52 Week High
$109.00
$39.51

Technical Indicators

Market Signals
Indicator
NKTR
BY
Relative Strength Index (RSI) 54.99 68.24
Support Level $64.28 $32.02
Resistance Level $76.78 N/A
Average True Range (ATR) 3.57 0.72
MACD 0.17 0.03
Stochastic Oscillator 66.12 85.48

Price Performance

Historical Comparison
NKTR
BY

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through a wholly-owned subsidiary of Byline Bank.

Share on Social Networks: